Aysha Shaikh

Hôpital Pasteur

Papers

2

Total Citations

31

H-Index

2

About

Dr. Aysha Shaikh is a prominent urologic oncologist whose research focuses on optimizing surgical outcomes in robotic-assisted partial nephrectomy (RAPN) for kidney cancer. Her work centers on two critical, debated aspects of nephron-sparing surgery: the management of hilar control and the prognostic significance of positive surgical margins. In her landmark 2021 multicenter study within the French UROCCR network (17 citations), Dr. Shaikh systematically compared oncological outcomes between on-clamp and off-clamp hilar control approaches, providing crucial evidence to guide intraoperative decision-making. She further advanced the field with the 2022 MARGINS study (14 citations), a rigorous analysis of recurrence-free, metastasis-free, and overall survival following RAPN. By directly comparing patients with positive versus negative surgical margins, Dr. Shaikh’s work helps clarify the true oncological risk associated with margin status, informing postoperative surveillance and adjuvant therapy strategies. Her contributions, grounded in high-quality, multi-institutional data, are shaping contemporary standards for kidney cancer surgery and have earned her recognition as a key investigator within the UROCCR network.

Research Focus

Key Achievements

2
H-Index
2
Papers
31
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Evaluation of oncological outcomes of robotic partial nephrectomy according to the type of hilar control approach (On-clamp vs Off-clamp), a multicentric study of the French network of research on kidney cancer—UROCCR 58-NCT03293563
17 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 33
🏛 Institutions: Hôpital Pasteur

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago